Canada House Cannabis Group Inc. Logo

Canada House Cannabis Group Inc.

CHV.CN

(1.5)
Stock Price

0,04 CAD

1.39% ROA

6.79% ROE

0x PER

Market Cap.

1.615.341,00 CAD

1391.79% DER

0% Yield

1.3% NPM

Canada House Cannabis Group Inc. Stock Analysis

Canada House Cannabis Group Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Canada House Cannabis Group Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 ROE

The stock's ROE falls within an average range (6.79%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (1.39%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

5 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (98), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

6 DER

The company has a high debt to equity ratio (1392%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

10 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

11 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

Canada House Cannabis Group Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Canada House Cannabis Group Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Buy

Canada House Cannabis Group Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Canada House Cannabis Group Inc. Revenue
Year Revenue Growth
1997 1
1998 1 0%
1999 1 0%
2000 125.223 100%
2001 289.152 56.69%
2002 685 -42111.97%
2003 54 -1168.52%
2004 0 0%
2005 793.980 100%
2006 1.349.776 41.18%
2007 1.547.048 12.75%
2008 1.548.768 0.11%
2009 51.305.027 96.98%
2010 54.915.149 6.57%
2011 54.893.864 -0.04%
2012 59.474 -92198.93%
2013 42.259 -40.74%
2014 14.302 -195.48%
2015 0 0%
2016 0 0%
2017 6.207.294 100%
2018 3.289.000 -88.73%
2019 4.875.000 32.53%
2020 5.310.000 8.19%
2021 10.560.000 49.72%
2023 51.055.148 79.32%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Canada House Cannabis Group Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 453.227 100%
2009 -9.501 4870.31%
2010 8.771 208.32%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Canada House Cannabis Group Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 2.176.218 100%
2010 2.098.373 -3.71%
2011 1.689.476 -24.2%
2012 448.662 -276.56%
2013 305.307 -46.95%
2014 129.503 -135.75%
2015 2.317.363 94.41%
2016 1.724.830 -34.35%
2017 7.583.625 77.26%
2018 9.658.000 21.48%
2019 10.515.000 8.15%
2020 8.411.000 -25.01%
2021 8.714.000 3.48%
2023 10.188.736 14.47%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Canada House Cannabis Group Inc. EBITDA
Year EBITDA Growth
1997 -159.429
1998 -736.238 78.35%
1999 -119.826 -514.42%
2000 -311.930 61.59%
2001 -893.300 65.08%
2002 -61.844 -1344.44%
2003 -27.567 -124.34%
2004 -20.214 -36.38%
2005 715.753 102.82%
2006 258.878 -176.48%
2007 248.344 -4.24%
2008 188.054 -32.06%
2009 436.393 56.91%
2010 433.086 -0.76%
2011 966.883 55.21%
2012 -635.282 252.2%
2013 -165.831 -283.09%
2014 -136.031 -21.91%
2015 -2.572.190 94.71%
2016 -1.772.163 -45.14%
2017 -2.890.423 38.69%
2018 -7.009.000 58.76%
2019 -7.451.000 5.93%
2020 -2.075.000 -259.08%
2021 -6.272.000 66.92%
2023 4.452.864 240.85%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Canada House Cannabis Group Inc. Gross Profit
Year Gross Profit Growth
1997 1
1998 1 0%
1999 1 0%
2000 125.223 100%
2001 289.152 56.69%
2002 685 -42111.97%
2003 54 -1168.52%
2004 0 0%
2005 290.519 100%
2006 584.333 50.28%
2007 779.621 25.05%
2008 814.058 4.23%
2009 2.744.607 70.34%
2010 2.630.971 -4.32%
2011 2.766.788 4.91%
2012 -362.618 863%
2013 42.259 958.08%
2014 14.302 -195.48%
2015 0 0%
2016 0 0%
2017 6.207.294 100%
2018 3.289.000 -88.73%
2019 3.789.000 13.2%
2020 3.385.000 -11.94%
2021 2.958.000 -14.44%
2023 13.099.124 77.42%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Canada House Cannabis Group Inc. Net Profit
Year Net Profit Growth
1997 -142.773
1998 -723.113 80.26%
1999 -248.402 -191.11%
2000 -291.378 14.75%
2001 -1.179.999 75.31%
2002 -61.844 -1808.03%
2003 -27.567 -124.34%
2004 -20.214 -36.38%
2005 220.746 109.16%
2006 -65.713 435.92%
2007 -101.365 35.17%
2008 -656.941 84.57%
2009 -1.358.614 51.65%
2010 -1.211.850 -12.11%
2011 -1.833.087 33.89%
2012 3.427.784 153.48%
2013 144.954 -2264.74%
2014 -545.331 126.58%
2015 -8.875.420 93.86%
2016 -2.947.106 -201.16%
2017 -14.453.068 79.61%
2018 -12.917.000 -11.89%
2019 -11.415.000 -13.16%
2020 -9.520.000 -19.91%
2021 -11.365.000 16.23%
2023 -747.392 -1420.62%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Canada House Cannabis Group Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 -5
1998 -24 79.17%
1999 -8 -200%
2000 -7 -33.33%
2001 -19 68.42%
2002 -1 -1800%
2003 -1 0%
2004 0 0%
2005 1 0%
2006 0 0%
2007 0 0%
2008 -2 100%
2009 -3 66.67%
2010 -3 -50%
2011 -4 50%
2012 8 150%
2013 0 0%
2014 -1 100%
2015 -6 83.33%
2016 -2 -200%
2017 -8 71.43%
2018 -3 -250%
2019 -2 -100%
2020 -1 0%
2021 -1 0%
2023 -75 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Canada House Cannabis Group Inc. Free Cashflow
Year Free Cashflow Growth
1997 -15.524
1998 -238.481 93.49%
1999 -146.829 -62.42%
2000 -520.582 71.8%
2001 -903.796 42.4%
2002 -70.931 -1174.19%
2003 -26.581 -166.85%
2004 -12.614 -110.73%
2005 -409.967 96.92%
2006 -727.017 43.61%
2007 173.953 517.94%
2008 -151.888 214.53%
2009 268.946 156.48%
2010 454.529 40.83%
2011 50.833 -794.16%
2012 -148.144 134.31%
2013 62.003 338.93%
2014 -1.337.774 104.63%
2015 -3.522.278 62.02%
2016 -471.256 -647.42%
2017 -3.318.790 85.8%
2018 -6.667.000 50.22%
2019 -11.243.000 40.7%
2020 -6.036.000 -86.27%
2021 -4.149.000 -45.48%
2023 1.821.182 327.82%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Canada House Cannabis Group Inc. Operating Cashflow
Year Operating Cashflow Growth
1997 -9.091
1998 -238.481 96.19%
1999 -146.829 -62.42%
2000 -441.771 66.76%
2001 -888.419 50.27%
2002 -70.931 -1152.51%
2003 -26.581 -166.85%
2004 -12.614 -110.73%
2005 -38.266 67.04%
2006 -206.069 81.43%
2007 734.204 128.07%
2008 -8.320 8924.57%
2009 369.595 102.25%
2010 613.067 39.71%
2011 81.432 -652.86%
2012 -148.144 154.97%
2013 62.003 338.93%
2014 -1.337.774 104.63%
2015 -2.254.848 40.67%
2016 -460.159 -390.01%
2017 -1.803.152 74.48%
2018 -4.241.000 57.48%
2019 -6.081.000 30.26%
2020 -5.279.000 -15.19%
2021 -3.355.000 -57.35%
2023 2.140.029 256.77%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Canada House Cannabis Group Inc. Capital Expenditure
Year Capital Expenditure Growth
1997 6.433
1998 0 0%
1999 0 0%
2000 78.811 100%
2001 15.377 -412.53%
2002 0 0%
2003 0 0%
2004 0 0%
2005 371.701 100%
2006 520.948 28.65%
2007 560.251 7.02%
2008 143.568 -290.23%
2009 100.649 -42.64%
2010 158.538 36.51%
2011 30.599 -418.11%
2012 0 0%
2013 0 0%
2014 0 0%
2015 1.267.430 100%
2016 11.097 -11321.38%
2017 1.515.638 99.27%
2018 2.426.000 37.53%
2019 5.162.000 53%
2020 757.000 -581.9%
2021 794.000 4.66%
2023 318.847 -149.02%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Canada House Cannabis Group Inc. Equity
Year Equity Growth
1997 1.246.430
1998 544.317 -128.99%
1999 295.915 -83.94%
2000 1.260.252 76.52%
2001 80.253 -1470.35%
2002 18.409 -335.94%
2003 -9.158 301.02%
2004 -29.372 68.82%
2005 1.400.663 102.1%
2006 1.334.950 -4.92%
2007 1.332.365 -0.19%
2008 2.770.601 51.91%
2009 1.511.418 -83.31%
2010 -105.729 1529.52%
2011 -2.161.066 95.11%
2012 1.266.718 270.6%
2013 1.286.672 1.55%
2014 741.341 -73.56%
2015 -481.248 254.05%
2016 -1.619.171 70.28%
2017 -1.209.094 -33.92%
2018 6.064.000 119.94%
2019 8.398.000 27.79%
2020 5.074.000 -65.51%
2021 6.873.000 26.17%
2023 1.353.994 -407.61%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Canada House Cannabis Group Inc. Assets
Year Assets Growth
1997 1.430.293
1998 595.002 -140.38%
1999 325.046 -83.05%
2000 1.435.365 77.35%
2001 92.545 -1450.99%
2002 22.104 -318.68%
2003 3.283 -573.29%
2004 2.563 -28.09%
2005 2.031.726 99.87%
2006 3.739.278 45.67%
2007 3.769.881 0.81%
2008 10.517.469 64.16%
2009 9.616.232 -9.37%
2010 9.512.944 -1.09%
2011 6.603.527 -44.06%
2012 2.352.144 -180.75%
2013 1.422.208 -65.39%
2014 1.292.128 -10.07%
2015 2.059.589 37.26%
2016 1.974.567 -4.31%
2017 5.394.924 63.4%
2018 15.050.000 64.15%
2019 16.307.000 7.71%
2020 14.428.000 -13.02%
2021 36.992.000 61%
2023 33.532.499 -10.32%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Canada House Cannabis Group Inc. Liabilities
Year Liabilities Growth
1997 183.863
1998 50.685 -262.76%
1999 29.131 -73.99%
2000 175.113 83.36%
2001 12.292 -1324.61%
2002 3.695 -232.67%
2003 12.441 70.3%
2004 31.935 61.04%
2005 631.063 94.94%
2006 2.404.328 73.75%
2007 2.437.516 1.36%
2008 7.746.868 68.54%
2009 8.104.814 4.42%
2010 9.618.673 15.74%
2011 8.764.593 -9.74%
2012 1.085.426 -707.48%
2013 135.536 -700.84%
2014 550.787 75.39%
2015 2.540.837 78.32%
2016 3.593.738 29.3%
2017 6.604.018 45.58%
2018 8.986.000 26.51%
2019 7.909.000 -13.62%
2020 9.354.000 15.45%
2021 30.119.000 68.94%
2023 32.178.505 6.4%

Canada House Cannabis Group Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
3590.88
Net Income per Share
46.62
Price to Earning Ratio
0x
Price To Sales Ratio
0.04x
POCF Ratio
0
PFCF Ratio
0.54
Price to Book Ratio
0
EV to Sales
0.54
EV Over EBITDA
2.34
EV to Operating CashFlow
5.41
EV to FreeCashFlow
6.53
Earnings Yield
1331.86
FreeCashFlow Yield
1.85
Market Cap
0,00 Bil.
Enterprise Value
0,02 Bil.
Graham Number
376.85
Graham NetNet
-2003.21

Income Statement Metrics

Net Income per Share
46.62
Income Quality
2.85
ROE
0.07
Return On Assets
0.01
Return On Capital Employed
0.46
Net Income per EBT
1.04
EBT Per Ebit
0.07
Ebit per Revenue
0.17
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0.27
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.54
Operating Profit Margin
0.17
Pretax Profit Margin
0.01
Net Profit Margin
0.01

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
360.1
Free CashFlow per Share
298.62
Capex to Operating CashFlow
-0.17
Capex to Revenue
-0.02
Capex to Depreciation
-0.27
Return on Invested Capital
0.31
Return on Tangible Assets
0.01
Days Sales Outstanding
84.92
Days Payables Outstanding
256.17
Days of Inventory on Hand
218.47
Receivables Turnover
4.3
Payables Turnover
1.42
Inventory Turnover
1.67
Capex per Share
-61.48

Balance Sheet

Cash per Share
96,75
Book Value per Share
135,40
Tangible Book Value per Share
135.4
Shareholders Equity per Share
135.4
Interest Debt per Share
2345.12
Debt to Equity
13.92
Debt to Assets
0.56
Net Debt to EBITDA
2.15
Current Ratio
0.96
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
13.92
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,01 Bil.
Average Inventory
6900850
Debt to Market Cap
11.67

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Canada House Cannabis Group Inc. Dividends
Year Dividends Growth

Canada House Cannabis Group Inc. Profile

About Canada House Cannabis Group Inc.

Canada House Cannabis Group Inc., through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics. It also provides a cloud-based software that links physicians, providers, and patients to data that supports treatment with medical cannabis. The company serves its products under the Abba Medix, ICM Air, ICM Fogo, H-Series, Fleurs de chez nous, and Vandoos brand names. Canada House Cannabis Group Inc. is headquartered in Pickering, Canada.

CEO
Mr. Michael Perron CPA, M.A.
Employee
127
Address
1773 Bayly Street
Pickering, ONL1W2Y7

Canada House Cannabis Group Inc. Executives & BODs

Canada House Cannabis Group Inc. Executives & BODs
# Name Age
1 Mr. Michael Perron C.P.A., M.A.
Chief Executive Officer
70
2 Mr. Christopher Churchill-Smith
Chief Executive Officer & Director
70
3 Ms. Liana Del Medico
Director of Communications & Investor Relations
70
4 Ms. Peili Miao CGA, CPA
Chief Financial Officer & Financial Controller
70
5 Mr. Michael Perron CPA, M.A.
Chief Executive Officer
70
6 Mr. Steven Pearce
Vice President of Legal
70

Canada House Cannabis Group Inc. Competitors